2-D DIGE to expedite downstream process development for human monoclonal antibody purification

Protein Expression and Purification

Volumn 66, Issue 1, 2009, Pages 58-65

  Grzeskowiak, Julita K ^a   Tscheliessnig, Anne ^b   Toh, Poh Choo ^b   Chusainow, Janet ^b   Lee, Yih Yean ^b   Wong, Niki ^b   Jungbauer, Alois ^a,b  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

2 D DIGE; Affinity chromatography; IgG; Recombinant antibody; Staphylococcus Protein A chromatography

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CELL SURVIVAL; CHO CELL; CHROMATOGRAPHY; CRICETULUS; FLUORESCENCE; HAMSTER; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL SURVIVAL; CHO CELLS; CHROMATOGRAPHY; CRICETINAE; CRICETULUS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENCE; HUMANS; REPRODUCIBILITY OF RESULTS;

CRICETULUS GRISEUS; STAPHYLOCOCCUS;

EID: 63949084875     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.01.007     Document Type: Article

References (37)

1. Shukla A.A., Hubbard B., Tressel T., Guhan S., and Low D. Downstream processing of monoclonal antibodies-application of platform approaches. J. Chrom. B 848 (2007) 28-39
2. Low D., O'Leary R., and Pujar N.S. Future of antibody purification. J. Chrom. B 848 (2007) 48-63
3. Dübel S. Recombinant therapeutic antibodies. Appl. Microbiol. Biotech. 74 (2007) 723-729
4. Hudson P.J. Recombinant antibody constructs in cancer therapy. Curr. Opin. Immunol. 11 (1999) 548-557
5. Hacker D.L., Derow E., and Wurm F.M. The CELO adenovirus Gam1 protein enhances transient and stable recombinant protein expression in Chinese hamster ovary cells. J. Biotech. 117 (2005) 21-29
6. Werner R.G., Noe W., Kopp K., and Schlüter M. Appropriate mammalian expression systems for biopharmaceuticals. Arzneimittel-Forschung/Drug Res. 48 (1998) 870-880
7. Schirrmann T., Al-Halabi L., Dübel S., and Hust M. Production systems for recombinant antibodies. Frontiers Biosci. 13 (2008) 4576-4594
8. Werner R.G., and Noe W. Mammalian cell cultures. Part II: genetic engineering, protein glycosylation, fermentation and process control. Arzneimittel-Forschung/Drug Res. 43 (1993) 1242-1249
9. Becker E., Florin L., Pfizenmaier K., and Kaufmann H. An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes. J. Biotech. 135 (2008) 217-223
10. Birch J.R., and Racher A.J. Antibody production. Adv. Drug Del. Rev. 58 (2006) 671-685
11. Werner R.G., Kopp K., and Schlueter M. Glycosylation of therapeutic proteins in different production systems. Acta Paediatrica, Intl. J. Paediatrics 96 (2007) 17-22
12. Monica T.J., Goochee C.F., and Maiorella B.L. Comparative biochemical characterization of a human igm produced in both ascites and in vitro cell culture. Nat. Biotech. 11 (1993) 512-515
13. Sinclair A.M., and Elliott S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J. Pharm. Sci. 94 (2005) 1626-1635
14. Rudd P.M., and Dwek R.A. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 32 (1997) 1-100
15. Sethuraman N., and Stadheim T.A. Challenges in therapeutic glycoprotein production. Curr. Opin. Biotech. 17 (2006) 341-346
16. Werner R.G. Economic aspects of commercial manufacture of biopharmaceuticals. J. Biotech. 113 (2004) 171-182
17. Boucher G., Broly H., and Lemieux R. Restricted use of cationic germline V(H) gene segments in human Rh(D) red cell antibodies. Blood 89 (1997) 3277-3286
18. Ahrer K., and Jungbauer A. Chromatographic and electrophoretic characterization of protein variants. J. Chrom. B 841 (2006) 110-122
19. A.M. Marmont, Erythropoietin: biochemical profile, biological records, indications and therapeutic results in hematology, Eritropoietina: Profilo biochimico, ricordi biologici, indicazioni e risultati terapeutici in ematologia 83 (1997).
20. Elliott S., Egrie J., Browne J., Lorenzini T., Busse L., Rogers N., and Ponting I. Control of rHuEPO biological activity: the role of carbohydrate. Exp. Hematol. 32 (2004) 1146-1155
21. Hahn R., Schlegel R., and Jungbauer A. Comparison of protein A affinity sorbents. J. Chrom. B 790 (2003) 35-51
22. Yu D., McLean M.D., Hall J.C., and Ghosh R. Purification of monoclonal antibody from tobacco extract using membrane-based bioseparation techniques. J. Membrane Sci. 323 (2008) 159-166
23. Ghose S., Hubbard B., and Cramer S.M. Evaluation and comparison of alternatives to protein A chromatography: mimetic and hydrophobic charge induction chromatographic stationary phases. J. Chrom. A 1122 (2006) 144-152
24. Karlsson D., Jakobsson N., Brink K.J., Axelsson A., and Nilsson B. Methodologies for model calibration to assist the design of a preparative ion-exchange step for antibody purification. J. Chrom. A 1033 (2004) 71-82
25. Boonnak K., Slike B.M., Burgess T.H., Mason R.M., Wu S.J., Sun P., Porter K., Rudiman I.F., Yuwono D., Puthavathana P., and Marovich M.A. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82 (2008) 3939-3951
26. Flatman S., Alam I., Gerard J., and Mussa N. Process analytics for purification of monoclonal antibodies. J. Chrom. B 848 (2007) 79-87
27. Orange P., Hawkins E., Story C., and Flower S. Fluorescence 2-D difference gel electrophoresis. Life Sci. News 5 (2000)
28. Guerreiro N., Staufenbiel M., and Gomez-Mancilla B. Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypes. J. Alzheimer's Disease 13 (2008) 17-30
29. Wu D., Tomonaga T., Sogawa K., Satoh M., Sunaga M., Nezu M., Oh-Ishi M., Kodera Y., Maeda T., Ochiai T., and Nomura F. Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis alcoholism. Clin. Exp. Res. 31 (2007)
30. Steiner S., and Witzmann F.A. Proteomics: applications and opportunities in preclinical drug development. Electrophoresis 21 (2000) 2099-2104
31. Lu G.D., Shen H.M., Ong C.N., and Chung M.C.M. Anticancer effects of aloe-emodin on HepG2 cells: cellular and proteomic studies proteomics. Clin. Appl. 1 (2007) 410-419
32. Rozanas C.R., and Loyland S.M. Capabilities using 2-D DIGE in proteomics research: the new gold standard for 2-D gel electrophoresis. Methods Mol. Biol. (Clifton, NJ) 441 (2008) 1-18
33. Corzett T.H., Fodor I.K., Choi M.W., Walsworth V.L., Chromy B.A., Turteltaub K.W., and McCutchen-Maloney S.L. Statistical analysis of the experimental variation in the proteomic characterization of human plasma by two-dimensional difference gel electrophoresis. J. Proteome Res. 5 (2006) 2611-2619
34. Zhang X., Guo Y., Song Y., Sun W., Yu C., Zhao X., Wang H., Jiang H., Li Y., Qian X., Jiang Y., and He F. Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis. Proteomics 6 (2006) 5260-5268
35. Nielsen L.K., Green T.H., Norderhaug L., Sandlie I., and Dziegiel M.H. Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-D. Transfusion 47 (2007) 306-315
36. Chusainow J., Yang Y.S., Yeo J.H.M., Toh P.C., Asvadi P., Wong N.S.C., and Yap M.G.S. A study of monoclonal antibody-producing CHO cell lines: What makes a stable high producer?. Biotech Bioeng 102 (2009) 1182-1196
37. Heukeshoven J., and Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6 (1985) 103-112